PUBLIC COMPANY
saveABBVIE
USupdated 3mo ago
community read0 votes
pipeline
0
marketed
0
phase 3
0
catalysts ytd
0
approvals ytd
0
recalls ytd
0
Pipeline(0)
no pipeline products on record
Upcoming
no upcoming catalysts on record
Recent(90d)
nothing in the last 90 days
view all catalysts →Active trials
- phase2A Study of Venetoclax in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
- phase2A Study to Assess Adverse Events and Change in Disease Activity With Treatment Combinations With Telisotuzumab Adizutecan in Adults Participants With Pancreatobiliary Cancers
- phase3A Study to Learn More About How Risankizumab Works in Young Participants With Ulcerative Colitis
- phase3ELAPR002f Injectable Gel in the Treatment of Atrophic Acne Scars
- phase3A Study of the Efficacy and Safety of Risankizumab in Participants With Crohn's Disease
- phase1A Study to Assess Adverse Events and Change in Disease Activity of Intravenously (IV) Infused Etentamig (ABBV-383) in Combination With Anti-Cancer Regimens for the Treatment of Adult Participants With Relapsed/Refractory Multiple Myeloma
- phase3Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib Compared to Subcutaneous Adalimumab in Adult Participants With Moderate to Severe Rheumatoid Arthritis
- phase1Study to Evaluate Adverse Events, Change in Disease Activity, and How Intravenously Infused ABBV-291 Moves Through the Body in Adult Participants With Non-Hodgkin's Lymphoma
🐶 Hiring Signal
News
- Trump's FDA pick Overton good for psychedelics, new pain meds but bad for vaccines: analystsIf confirmed by the Senate, Heidi Overton—officially revealed Wednesday as President Donald Trump’s choice for FDA commissioner—is expected to be a boon for developers of psychedelic therapeutics a…biospace · 5h ago
- Kolon TissueGene cuts 37 US staffers after Phase 3 failFollow along as BioSpace tracks job cuts and restructuring initiatives.biospace · 11h ago
- 11 companies hiring in New JerseyLooking for a biopharma job in New Jersey? Job postings in the area have increased year over year, according to BioSpace data. Here are 11 companies with open roles.biospace · 11h ago
- Merck and Sarah Cannon team up to boost oncology trial efficiencyOncology R&D organization Sarah Cannon Research Institute (SCRI) announced a collaboration with Merck & Co. to increase patient access to oncology trials at community-based sites in the U.S.fiercebiotech · 13h ago
- Merck and Sarah Cannon team up to boost oncology trial efficiencyOncology R&D organization Sarah Cannon Research Institute (SCRI) announced a collaboration with Merck & Co. to increase patient access to oncology trials at community-based sites in the U.S.fiercebiotech · 1d ago
- With tech backing, AI biotechs force biopharma into ‘fail-fast’ drug developmentAI is quickly becoming a central force in drug development, from powering pharma engines to permanently rewiring the capital markets.biospace · 7d ago
- AbbVie, Novartis and Bristol Myers file 340B lawsuits in IllinoisThe pharma industry is bringing its 340B fight to Illinois. AbbVie, Novartis and Bristol Myers Squibb each filed separate lawsuits over the last week against an Illinois state law that seeks to reg…endpoints · 8d ago
- STAT+: Pharmalittle: We’re reading about an FDA rejection, 340B court battles, and moreThe FDA rejected a radiopharmaceutical therapy because of manufacturing issues, halting what would have been a competitor for Novartisstat · 8d ago
- Sionna cystic fibrosis drug fails key trial, removing threat to VertexSionna’s medicine didn’t have a meaningful additive impact when combined with Vertex’s top-selling Trikafta, surprising analysts and collapsing company shares.biopharma_dive · 9d ago
- STAT+: Pharmalittle: We’re reading about a Sanofi drug shortage, a Jazz Pharma deal, and moreSanofi is experiencing shortages of two medicines used to treat Pompe disease after the FDA warned the company over manufacturing issuesstat · 9d ago
comments(0)
5-min edit window · permanent after that